The price of insulin per person has doubled over the past 5 years, and it's not due to an increase in demand.

Concerned by the lack of competition in the U.S. generic market, Sen. Elizabeth Warren has proposed creating a new drug manufacturing department.

Express Scripts' new Flex formulary has been touted as an alternative to the rebate-based system, but who really benefits?

A handful of companies have recently announced plans to reduce deductibles or cover more care before workers are exposed to the cost.